Firm intends to develop its community of longevity-focused precision drugs facilities within the US and internationally.
Precision drugs firm Human Longevity, Inc. (HLI) has efficiently raised $39.8 million in an “upsized” Sequence B financing spherical to additional develop its synthetic intelligence-driven well being threat and suggestion platform, and introduce new applied sciences and providers associated to longevity. Co-founded in 2013 by genomics pioneer Dr J Craig Venter, the corporate’s mission is to increase human well being and efficiency past the standard medical deal with treating diseases.
San Francisco-based HLI, which leverages superior applied sciences to increase human lifespan and healthspan, additionally plans to make use of the brand new funding to help world enlargement of its clinics, with new websites deliberate past its present areas within the US. The corporate, which operates well being evaluation facilities in San Francisco and San Diego, says it expects to open future areas in Europe, Asia, Saudi Arabia, and different GCC nations.
HLI, which not too long ago introduced a strategic partnership with the Chopra Foundation, goals to shift healthcare from a reactive strategy to a extra proactive, preventive, and customized system. By frequently analyzing well being information from its shoppers, the corporate seeks to establish potential well being points early, enabling focused interventions that may lengthen not solely lifespan but additionally the interval of wholesome dwelling, or healthspan.
Early detection of well being dangers equivalent to most cancers, heart problems, neurodegenerative problems and metabolic situations permits for well timed intervention, which not solely saves lives however can even assist cut back total healthcare prices. By catching potential well being points earlier than they turn into critical situations, HLI claims its strategy presents the potential for higher well being outcomes and extra environment friendly administration of sources within the healthcare system.
On the core of HLI’s providing is the 100+ Longevity Care program, which is designed to detect early indicators of age-related illnesses and supply interventions geared toward growing each healthspan and lifespan. This system makes use of a wide range of instruments to collect well being information, together with complete genome sequencing, superior imaging strategies like whole-body and mind MRIs, complete cardiac evaluations, physique composition analyses, superior blood biomarkers, and wearable gadgets. This mix of knowledge and know-how is designed to allow a extremely customized strategy to well being administration, with the purpose of decreasing organic age and stopping illness.
Past its work with its shoppers, HLI can also be targeted on conducting longevity analysis, together with a key study in 2020, which demonstrated how the mixing of whole-genome sequencing, metabolomics, and superior imaging can establish, and assist mitigate, main well being dangers.
The Sequence B spherical, which exceeded its preliminary goal, was led by TVM Capital Healthcare and noticed participation from each new and current buyers, together with Panacea Enterprise and Rising Expertise Companions.
